KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corpay (CPAY) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Corpay (CPAY) over the last 17 years, with Q3 2025 value amounting to $2.9 billion.

  • Corpay's Cash & Equivalents rose 12316.57% to $2.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 billion, marking a year-over-year increase of 12316.57%. This contributed to the annual value of $2.9 billion for FY2024, which is 10888.05% up from last year.
  • According to the latest figures from Q3 2025, Corpay's Cash & Equivalents is $2.9 billion, which was up 12316.57% from $3.3 billion recorded in Q2 2025.
  • Over the past 5 years, Corpay's Cash & Equivalents peaked at $3.3 billion during Q2 2025, and registered a low of $958.3 million during Q1 2021.
  • In the last 5 years, Corpay's Cash & Equivalents had a median value of $1.4 billion in 2023 and averaged $1.7 billion.
  • As far as peak fluctuations go, Corpay's Cash & Equivalents plummeted by 2149.49% in 2024, and later surged by 14591.85% in 2025.
  • Over the past 5 years, Corpay's Cash & Equivalents (Quarter) stood at $1.5 billion in 2021, then dropped by 5.58% to $1.4 billion in 2022, then decreased by 3.17% to $1.4 billion in 2023, then soared by 108.88% to $2.9 billion in 2024, then increased by 0.21% to $2.9 billion in 2025.
  • Its Cash & Equivalents stands at $2.9 billion for Q3 2025, versus $3.3 billion for Q2 2025 and $2.8 billion for Q1 2025.